NAFDAC Warns Against Use Of Deekins Amoxycillin 500mg

The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigerians to stop using Deekins Amoxycillin 500mg capsules due to reports of severe adverse reactions linked to the product.

This alert was issued during a press briefing in Abuja by NAFDAC’s Director-General, Prof. Mojisola Adeyeye.

According to Adeyeye, the investigation focuses on a batch of the drug (lot number 4C639001), manufactured by Ecomed Pharma Limited and marketed by Devine Kings Pharmaceutical Limited. Reports of three significant adverse reactions from a hospital prompted the investigation.

“A statement from Mr. Kingsley Ekeanyanwu, representing Devine Kings Pharmaceutical Limited, revealed that only 20 packets of this batch were officially produced for registration renewal,” she explained. “However, 790 packs of this batch, now recalled, were not manufactured by the registered company.”

NAFDAC has sent samples of the suspected substandard product for laboratory analysis, and investigations are ongoing. The agency has invited key personnel, including the Quality Control and Production Managers, for questioning. Additionally, the Pharmacy Council of Nigeria and the responsible pharmacist have been informed.

The public is advised to avoid using the affected batch of Deekins Amoxycillin 500mg capsules. NAFDAC urges distributors, healthcare providers, and patients to be extra vigilant when purchasing medical products, ensuring they are sourced from authorized suppliers and in proper condition.

“Anyone in possession of this product should return it to the nearest NAFDAC office immediately,” Adeyeye stated. “If you or someone you know has used this product and experienced adverse reactions, seek immediate medical attention.”

NAFDAC has been actively informing the public since December 3, 2024, about the recall of this product. Healthcare professionals and the public are encouraged to report any cases of substandard medicines or adverse side effects through NAFDAC’s electronic platforms or the Med-Safety app.

The agency continues to prioritize the safety and health of Nigerians by taking strict measures to address issues of substandard and falsified medical products.

Send Us A Press Statement Advertise With Us Contact Us

 And For More Nigerian News Visit GWG.NG